4月11日，京东健康（06618.HK）股价在盘中出现大幅上涨，涨幅达5.08%，引起市场广泛关注。
消息面上，京东健康宣布与云南白药集团深化战略合作，双方将在全品类供应链、全渠道零售及创新营销等领域展开深度合作。根据合作计划，云南白药集团将依托京东健康"B2C+O2O+线下自营"的全渠道零售网络，进一步扩充医药健康合作品类，加速药品、器械及健康产品的铺货。预计未来三年，双方合作的复合增长率将超过50%，这一消息极大地提振了投资者信心。
此外，南向资金连续4日增持京东健康也为股价上涨提供了支撑。4月10日，南向资金增持京东健康390.54万股，截至当日收盘，港股通共持有京东健康29713.07万股，占流通股9.29%。近20个交易日内，尽管京东健康股价下跌4.41%，但港股通仍累计增持1337.94万股，显示出机构投资者对公司前景的看好。这种持续的资金流入可能进一步推动了股价的上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.